Saham Charles River Labs (CRL)
Fundamental
Charles River Laboratories International, Inc. (CRL) mencatat kinerja mingguan yang kuat, naik dari sekitar $278 ke kisaran $292–$295. Kenaikan ini didorong oleh antusiasme terhadap Investor Day 2026 pada 24 September, di mana manajemen memperkenalkan strategi Pathway to Purpose dan program Create the Future yang menargetkan penghematan biaya lebih dari $300 million dari 2027–2030. Manajemen juga mengonfirmasi ulang target pendapatan organik dan non-GAAP EPS TA 2026 sebesar $11.15–$11.45 di batas atas rentang, memicu beberapa analis menaikkan target harga.
Berita terbaru
Tidak ada berita terbaru
Teknikal
Rating Analis
Financials
Performa
Utang & Neraca
Pendapatan ke Laba
2025Earnings
The company reported results on Aug 04 2026 and beat market expectations.
Tentang Charles River Labs
Charles River Laboratories International, Inc. (NYSE: CRL) adalah organisasi penelitian kontrak (CRO) global yang menyediakan produk dan layanan penting untuk mempercepat penelitian dan pengembangan obat. Sebagai mitra penting bagi industri farmasi dan bioteknologi, harga saham CRL sangat relevan bagi investor yang tertarik pada inovasi dalam ilmu hayati.
Eksekutif Utama
| Nama | Jabatan | Tahun Lahir |
|---|---|---|
| Ms. Birgit Girshick | CEO & Director | 1970 |
| Mr. Michael Gunnar Knell | Corporate Senior VP & Chief Accounting Officer | 1977 |
| Mr. Joseph W. LaPlume J.D. | Corporate Executive Vice President of Corporate Development & Strategy | 1974 |
| Ms. Victoria L. Creamer | Corporate Executive VP & Chief People Officer | 1970 |
| Mr. Glenn G. Coleman CPA | Corporate Executive VP & CFO | 1968 |
| Mr. Mark Mintz | Corporate EVP, Chief Information Officer & Global Shared Services | 1974 |
| Mr. Todd Spencer | Corporate Vice President of Investor Relations | — |
| Ms. Kerry Dailey | Corporate Senior VP & Chief Legal Officer | — |
| Ms. Amy E. Cianciaruso | Corporate Senior Vice President, Chief Communications Officer & Government Relations | — |
| Dr. Brian F. Bathgate Ph.D. | Corporate Senior Vice President of European Safety Assessment | 1960 |
Fundamental
Valuasi
Earnings Per Share
Income Statement
Dividen
Solvabilitas
Teknikal
Kata para ahli
10 Rating Analis Wall Street
Musiman
Perubahan harga bulanan (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.5 | +7.7 | -16.9 | +4.3 | ||||||||
| 2022 | -8.9 | -13.2 | -0.2 | -16.3 | -4.8 | -6.8 | +14.5 | -17.8 | -3.2 | +4.2 | +10.3 | -3.7 |
| 2023 | +11.4 | -11.6 | -9.5 | -5.1 | +1.7 | +7.1 | +0.4 | -1.2 | -6.5 | -12.9 | +17.6 | +17.2 |
| 2024 | -7.7 | +15.8 | +2.5 | -14.8 | -10.4 | -0.6 | +20.1 | -18.6 | +2.6 | -8.0 | +10.0 | -8.3 |
| 2025 | -9.8 | +2.3 | -7.9 | -18.7 | +16.0 | +12.4 | +9.9 | -2.2 | -3.0 | +5.6 | -0.4 | +13.3 |
| 2026 | +4.0 | -16.3 | -3.4 | -4.5 | +9.0 | +24.6 | +1.5 | +24.8 | +3.7 |
